IP Library › Granted Patent US 11,129,824
Granted Patent B2
US 11,129,824 · App. 16/063,279 · Granted Sep 28, 2021

Small molecules for inhibiting chemokine activity and/or cancer cells growth

Inventors: Amnon Peled (Tel-Aviv, IL); Michal Abraham (Mevasseret Zion, IL); Orly Eizenberg (Rechovot, IL)
Assignee: Biokine Therapeutics Ltd.
A61K31/4704A61P35/02A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,129,824
App. No.
16/063,279
Granted
Sep 28, 2021
Kind
B2
Abstract

Compounds capable of, or usable in, inducing death of cancer cells and/or modulating a biological activity of a chemokine e.g., cell migration, and/or treating diseases and disorders associated with a biological activity of a chemokine and/or cell migration, and/or inhibiting a kinase and/or in treating a disease or disorder associated with an activity of a kinase, such as cancer and inflammatory diseases and disorders, are provided herein. The compounds are collectively represented by Formulae Ia or Ib: wherein A, B D, E, G and R 1 -R 5 are as defined in the specification.

Claims (27)

1. A compound represented by Formula Ia and/or Ib:

wherein:

A is an alkyl being at least 4 carbon atoms in length;

B is selected from hydroxy and alkoxy;

D, E and G are each independently selected from hydrogen, hydroxy, alkoxy and alkyl, provided that (i) no more than one of D, E and G is said alkyl, (ii) at least one and no more than two of D, E and G are said alkoxy, and (iii) if two of D, E and G are said alkoxy, none of D, E and G is said alkyl;

R 1 is selected from hydrogen and alkyl; and

each of R 2 -R 5 is independently selected from hydrogen, hydroxy, halo, alkoxy, thioalkoxy, thiol, thioalkoxy and amine.

2. The compound of claim 1 , wherein B is alkoxy.

3. The compound of claim 1 , wherein E is alkoxy.

4. The compound of claim 2 , wherein E is alkoxy.

5. The compound of claim 1 , wherein D is alkoxy.

6. The compound of claim 2 , wherein D is alkoxy.

7. The compound of claim 3 , wherein D is alkoxy.

8. The compound of claim 4 , wherein D is alkoxy.

9. The compound of claim 1 , wherein G is alkoxy.

10. The compound of claim 1 , wherein G is hydrogen.

11. The compound of claim 1 , wherein B is alkoxy, E is alkoxy and G is alkoxy or hydrogen.

12. The compound of claim 11 , wherein D is alkoxy.

13. The compound of claim 1 , wherein D is said alkyl.

14. The compound of claim 13 , wherein G is hydrogen.

15. The compound of claim 13 , wherein B is alkoxy.

16. The compound of claim 13 , wherein B is alkoxy and E is alkoxy.

17. The compound of claim 1 , wherein when one of D, E and G is alkyl, said alkyl is at least 4 carbon atoms in length.

18. The compound of claim 1 , being:

19. The compound of claim 1 , being:

20. The compound of claim 1 , being:

21. The compound of claim 1 , being:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2022
From: BIOKINE THERAPEUTICS LTD.
To: ALONBIO LTD.
Reel/Frame 059543/0776 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2018
From: PELED, AMNON; ABRAHAM, MICHAL; EIZENBERG, ORLY
To: BIOKINE THERAPEUTICS LTD.
Reel/Frame 046209/0353 →
Continuity (2)
Provisional Application 62268586 · Dec 17, 2015
Related Publication 20190336492A1 · Nov 7, 2019
Cited By (2)
US 12,202,803 US 12,233,057